These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serum alpha 1-antichymotrypsin is not a useful marker for Alzheimer's disease or dementia in Parkinson's disease. Kuiper MA; van Kamp GJ; Bergmans PL; Scheltens P; Wolters EC J Neural Transm Park Dis Dement Sect; 1993; 6(2):145-9. PubMed ID: 8117411 [TBL] [Abstract][Full Text] [Related]
4. Serum heme oxygenase-1 levels are increased in Parkinson's disease but not in Alzheimer's disease. Mateo I; Infante J; Sánchez-Juan P; García-Gorostiaga I; Rodríguez-Rodríguez E; Vázquez-Higuera JL; Berciano J; Combarros O Acta Neurol Scand; 2010 Feb; 121(2):136-8. PubMed ID: 19785642 [TBL] [Abstract][Full Text] [Related]
5. Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in Alzheimer's disease patients and in Parkinson's disease patients. Genedani S; Rasio G; Cortelli P; Antonelli F; Guidolin D; Galantucci M; Fuxe K; Agnati LF Neurotox Res; 2004; 6(4):327-32. PubMed ID: 15545016 [TBL] [Abstract][Full Text] [Related]
6. Similarity and Differences in Inflammation-Related Characteristics of the Peripheral Immune System of Patients with Parkinson's and Alzheimer's Diseases. Boyko AA; Troyanova NI; Kovalenko EI; Sapozhnikov AM Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29211044 [TBL] [Abstract][Full Text] [Related]
8. Peripheral expression of MAPK pathways in Alzheimer's and Parkinson's diseases. Wang S; Zhang C; Sheng X; Zhang X; Wang B; Zhang G J Clin Neurosci; 2014 May; 21(5):810-4. PubMed ID: 24405770 [TBL] [Abstract][Full Text] [Related]
9. Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease. Heafield MT; Fearn S; Steventon GB; Waring RH; Williams AC; Sturman SG Neurosci Lett; 1990 Mar; 110(1-2):216-20. PubMed ID: 2325885 [TBL] [Abstract][Full Text] [Related]
10. Alteration of protein kinase C conformation in red blood cells: a potential marker for Alzheimer's disease but not for Parkinson's disease. Janoshazi A; Sellal F; Marescaux C; Danion JM; Warter JM; de Barry J Neurobiol Aging; 2006 Feb; 27(2):245-51. PubMed ID: 15893856 [TBL] [Abstract][Full Text] [Related]
11. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease. Clark LF; Kodadek T ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268 [TBL] [Abstract][Full Text] [Related]
12. Unfolded p53 as a Marker of Oxidative Stress in Mild Cognitive Impairment, Alzheimer's and Parkinson's Disease. García S; Amor-Gutiérrez O; Palomares-Albarrán M; Toyos-Rodríguez C; Cuetos F; Martínez C; Costa-García A; Fernández-Sánchez MT; de la Escosura-Muñiz A; Novelli A Curr Alzheimer Res; 2021; 18(9):695-700. PubMed ID: 34789127 [TBL] [Abstract][Full Text] [Related]
13. Ultrasensitive detection of blood biomarkers of Alzheimer's and Parkinson's diseases: a systematic review. Singh K; Cheung BM; Xu A Biomark Med; 2021 Dec; 15(17):1693-1708. PubMed ID: 34743546 [No Abstract] [Full Text] [Related]
14. An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases. Batistela MS; Josviak ND; Sulzbach CD; de Souza RL Int J Neurosci; 2017 Jun; 127(6):547-558. PubMed ID: 27381850 [TBL] [Abstract][Full Text] [Related]
15. Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease. Bach JP; Gold M; Mengel D; Hattesohl A; Lubbe D; Schmid S; Tackenberg B; Rieke J; Maddula S; Baumbach JI; Nell C; Boeselt T; Michelis J; Alferink J; Heneka M; Oertel W; Jessen F; Janciauskiene S; Vogelmeier C; Dodel R; Koczulla AR PLoS One; 2015; 10(7):e0132227. PubMed ID: 26168044 [TBL] [Abstract][Full Text] [Related]
16. Increases of pentraxin 3 plasma levels in patients with Parkinson's disease. Lee HW; Choi J; Suk K Mov Disord; 2011 Nov; 26(13):2364-70. PubMed ID: 21953577 [TBL] [Abstract][Full Text] [Related]
17. Vitamin D levels in Alzheimer's and Parkinson's diseases: a meta-analysis. Zhao Y; Sun Y; Ji HF; Shen L Nutrition; 2013 Jun; 29(6):828-32. PubMed ID: 23415143 [TBL] [Abstract][Full Text] [Related]
18. Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease. Irizarry MC; Yao Y; Hyman BT; Growdon JH; Praticò D Neurodegener Dis; 2007; 4(6):403-5. PubMed ID: 17934322 [TBL] [Abstract][Full Text] [Related]
19. S-methylation in motorneuron disease and Parkinson's disease. Waring RH; Steventon GB; Sturman SG; Heafield MT; Smith MC; Williams AC Lancet; 1989 Aug; 2(8659):356-7. PubMed ID: 2569553 [TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population. Chung SJ; Jung Y; Hong M; Kim MJ; You S; Kim YJ; Kim J; Song K Neurobiol Aging; 2013 Nov; 34(11):2695.e1-7. PubMed ID: 23820587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]